Tech Company M&A Transactions

SentreHEART Acquisition

On 8/13/2019, SentreHEART was purchased by AtriCure. AtriCure disclosed that the acquisition price was $300 million.

Transaction Overview

Company Name
Acquired By
Announced On
8/13/2019
Transaction Type
M&A
Amount
$300,000,000
M&A Terms
Under the terms of the agreement to acquire SentreHEART, the transaction consideration consists of an upfront payment of approximately $40 million in cash and AtriCure common stock, plus additional contingent consideration based on the achievement of certain clinical and reimbursement milestones over the next several years, all of which are value-creating events. Of the contingent consideration, $140 million is based on milestones related to the aMAZE™ IDE clinical trial, including PMA approval, and $120 million is based on a milestone related to reimbursement for the therapy involving SentreHEART devices. All contingent consideration would be payable in a combination of cash and stock.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
300 Saginaw Dr.
Redwood City, CA 94063
USA
Email Address
Overview
SentreHEART, Inc. is developing minimally invasive devices to protect and treat disorders of the heart.
Profile
SentreHEART LinkedIn Company Profile
Social Media
SentreHEART Company Twitter Account
Company News
SentreHEART News
Facebook
SentreHEART on Facebook
YouTube
SentreHEART on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Russell Seiber
  Russell Seiber LinkedIn Profile  Russell Seiber Twitter Account  Russell Seiber News  Russell Seiber on Facebook
Chief Financial Officer
Christopher Lowe
  Christopher Lowe LinkedIn Profile  Christopher Lowe Twitter Account  Christopher Lowe News  Christopher Lowe on Facebook
VP - Operations
Robert Strasser
  Robert Strasser LinkedIn Profile  Robert Strasser Twitter Account  Robert Strasser News  Robert Strasser on Facebook
VP - R & D
Greg Fung
  Greg Fung LinkedIn Profile  Greg Fung Twitter Account  Greg Fung News  Greg Fung on Facebook
VP - Regulatory Affairs
Pam Simons
  Pam Simons LinkedIn Profile  Pam Simons Twitter Account  Pam Simons News  Pam Simons on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/13/2019: Hazel Technologies venture capital transaction
Next: 8/13/2019: LucidWorks venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary